GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Price-to-Free-Cash-Flow

Terumo (Terumo) Price-to-Free-Cash-Flow

: 57.25 (As of Today)
View and export this data going back to 2008. Start your Free Trial

As of today (2024-04-20), Terumo's share price is $16.43. Terumo's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.29. Hence, Terumo's Price-to-Free-Cash-Flow Ratio for today is 57.25.

The historical rank and industry rank for Terumo's Price-to-Free-Cash-Flow or its related term are showing as below:

TRUMY' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 42.11   Med: 83.07   Max: 417.59
Current: 62.5

During the past 13 years, Terumo's highest Price-to-Free-Cash-Flow Ratio was 417.59. The lowest was 42.11. And the median was 83.07.

TRUMY's Price-to-Free-Cash-Flow is ranked worse than
76.19% of 336 companies
in the Medical Devices & Instruments industry
Industry Median: 31.135 vs TRUMY: 62.50

Terumo's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.10. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.29.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Terumo was 29.40% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 10.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -1.70% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 5.40% per year.

During the past 13 years, Terumo's highest 3-Year average Free Cash Flow per Share Growth Rate was 41.60% per year. The lowest was -28.00% per year. And the median was -0.60% per year.


Terumo Price-to-Free-Cash-Flow Historical Data

The historical data trend for Terumo's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.35 82.84 78.89 41.83 59.16

Terumo Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.69 59.16 113.99 83.57 56.90

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Terumo's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terumo Price-to-Free-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Terumo's Price-to-Free-Cash-Flow falls into.



Terumo Price-to-Free-Cash-Flow Calculation

Terumo's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=16.43/0.287
=57.25

Terumo's Share Price of today is $16.43.
Terumo's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.29.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Terumo  (OTCPK:TRUMY) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Terumo Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Terumo's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Terumo (Terumo) Business Description

Traded in Other Exchanges
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Terumo (Terumo) Headlines

From GuruFocus